As the European markets experience a boost, with the pan-European STOXX Europe 600 Index rising by 3.44% and major stock indexes showing gains, investors are increasingly looking for opportunities that may be trading below their intrinsic value. In this favorable economic climate, identifying undervalued stocks can be key to capitalizing on potential market inefficiencies and securing promising investment prospects. Top 10 Undervalued Stocks Based On Cash Flows In Europe Name Current Price Fair Value (Est) Discount (Est) SNGN Romgaz (BVB:SNG) RON5.77 RON11.22 48.6% Sword Group (ENXTPA:SWP) €32.10 €62.30 48.5% Rheinmetall (XTRA:RHM) €1645.00 €3281.01 49.9% Truecaller (OM:TRUE B) SEK74.95 SEK149.31 49.8% BAWAG Group (WBAG:BG) €97.00 €190.65 49.1% Net Insight (OM:NETI B) SEK2.855 SEK5.56 48.6% Stille (OM:STIL) SEK188.00 SEK367.62 48.9% Integrated System Credit Consulting Fintech (BIT:ISC) €1.56 €3.10 49.6% dormakaba Holding (SWX:DOKA) CHF704.00 CHF1396.69 49.6% Expert.ai (BIT:EXAI) €1.32 €2.60 49.3% Click here to see the full list of 168 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's uncover some gems from our specialized screener. Asker Healthcare Group Overview: Asker Healthcare Group AB is a company that supplies medical products and solutions to support patient care, with a market cap of SEK33.32 billion. Operations: The company's revenue segments are comprised of West at SEK7.22 billion, Central at SEK2.49 billion, and North (including East) at SEK5.49 billion. Estimated Discount To Fair Value: 16.3% Asker Healthcare Group, recently added to the OMX Nordic All-Share Index, completed an IPO raising SEK 8.89 billion. The stock trades at SEK 87, below its estimated fair value of SEK 104. Despite a high debt level and illiquid shares, earnings are forecast to grow significantly at 22.8% annually over the next three years, outpacing Swedish market expectations. Revenue growth is also expected to be higher than the market average but remains moderate overall. Upon reviewing our latest growth report, Asker Healthcare Group's projected financial performance appears quite optimistic. Navigate through the intricacies of Asker Healthcare Group with our comprehensive financial health report here.OM:ASKER Discounted Cash Flow as at May 2025 MilDef Group Overview: MilDef Group AB (publ) develops, manufactures, and sells rugged IT solutions across several countries including Sweden, Norway, and the United States, with a market cap of SEK12.31 billion. Operations: MilDef Group AB generates revenue from its Computer Hardware segment, amounting to SEK1.20 billion. Estimated Discount To Fair Value: 31.5% Story Continues MilDef Group, trading at SEK 261.6, is significantly undervalued with an estimated fair value of SEK 381.87. Despite recent shareholder dilution and insider selling, the company benefits from robust revenue growth forecasts of 31.3% annually, outpacing the Swedish market's average. Recent contracts with the Swedish Defence Materiel Administration and Clavister enhance its position in defense technology and cybersecurity markets. Profitability is anticipated within three years, suggesting strong future potential despite current volatility. Our growth report here indicates MilDef Group may be poised for an improving outlook. Dive into the specifics of MilDef Group here with our thorough financial health report.OM:MILDEF Discounted Cash Flow as at May 2025 Rheinmetall Overview: Rheinmetall AG is a global provider of mobility and security technologies, with a market cap of €71.45 billion. Operations: The company's revenue is derived from Power Systems (€2.04 billion), Vehicle Systems (€3.79 billion), Electronic Solutions (€1.73 billion), and Weapon and Ammunition (€2.78 billion). Estimated Discount To Fair Value: 49.9% Rheinmetall is significantly undervalued, trading at €1,645 against an estimated fair value of €3,281.01. The company forecasts earnings growth of 32.2% annually and revenue growth of 21.4%, both surpassing the German market averages. Recent strong performance in its defense segment led to a substantial increase in sales and operating profit, exceeding expectations with a first-quarter revenue of €2.31 billion and operating profit of €199 million, highlighting robust cash flow potential amidst geopolitical demand increases. Insights from our recent growth report point to a promising forecast for Rheinmetall's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Rheinmetall.XTRA:RHM Discounted Cash Flow as at May 2025 Taking Advantage Dive into all 168 of the Undervalued European Stocks Based On Cash Flows we have identified here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OM:ASKER OM:MILDEF and XTRA:RHM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 European Stocks Estimated To Be Trading At Discounts Up To 49.9%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...